{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:56:12Z","timestamp":1792432572897,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N006259\/1"],"award-info":[{"award-number":["MR\/N006259\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Identifying risk factors for impaired oral rotavirus vaccine (ORV) efficacy in low-income countries may lead to improvements in vaccine design and delivery. In this prospective cohort study, we measure maternal rotavirus antibodies, environmental enteric dysfunction (EED), and bacterial gut microbiota development among infants receiving two doses of Rotarix in India (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009307), Malawi (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009119), and the UK (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200960), using standardised methods across cohorts. We observe ORV shedding and seroconversion rates to be significantly lower in Malawi and India than the UK. Maternal rotavirus-specific antibodies in serum and breastmilk are negatively correlated with ORV response in India and Malawi, mediated partly by a reduction in ORV shedding. In the UK, ORV shedding is not inhibited despite comparable maternal antibody levels to the other cohorts. In both India and Malawi, increased microbiota diversity is negatively correlated with ORV immunogenicity, suggesting that high early-life microbial exposure may contribute to impaired vaccine efficacy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-27074-1","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T06:05:44Z","timestamp":1639548344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-109X","authenticated-orcid":false,"given":"Edward P. K.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8089-4021","authenticated-orcid":false,"given":"Christina","family":"Bronowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-0966","authenticated-orcid":false,"given":"Kulandaipalayam Natarajan C.","family":"Sindhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Babji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blossom","family":"Benny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Carmona-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedson","family":"Chasweka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"End","family":"Chinyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Queen","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidhartha","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-4507","authenticated-orcid":false,"given":"Nicholas C.","family":"Grassly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annai","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Immanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3376-8529","authenticated-orcid":false,"given":"Khuzwayo C.","family":"Jere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-4709","authenticated-orcid":false,"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mandolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Praharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakthavatsalam Sandya","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Silas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Kumar","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-8656","authenticated-orcid":false,"given":"Mark","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valsan Philip","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair C.","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5816-6423","authenticated-orcid":false,"given":"Miren","family":"Iturriza-G\u00f3mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"27074_CR1","first-page":"29","volume":"5","author":"M Mokomane","year":"2018","unstructured":"Mokomane, M., Kasvosve, I., de Melo, E., Pernica, J. M. & Goldfarb, D. M. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Ther. Adv. Infect. Dis. 5, 29\u201343 (2018).","journal-title":"Ther. Adv. Infect. Dis."},{"key":"27074_CR2","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","volume":"62","author":"JE Tate","year":"2016","unstructured":"Tate, J. E., Burton, A. H., Boschi-Pinto, C. & Parashar, U. D., World Health Organization-Coordinated Global Rotavirus Surveillance. N. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013. Clin. Infect. Dis. 62, S96\u2013S105 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"27074_CR3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger, C. et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 18, 1211\u20131228 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"27074_CR4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","volume":"370","author":"T Vesikari","year":"2007","unstructured":"Vesikari, T. et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370, 1757\u20131763 (2007).","journal-title":"Lancet"},{"key":"27074_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","volume":"362","author":"SA Madhi","year":"2010","unstructured":"Madhi, S. A. et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362, 289\u2013298 (2010).","journal-title":"N. Engl. J. Med"},{"key":"27074_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(18)30602-9","volume":"19","author":"JA Church","year":"2019","unstructured":"Church, J. A., Parker, E. P., Kirkpatrick, B. D., Grassly, N. C. & Prendergast, A. J. Interventions to improve oral vaccine performance: a systematic review and meta-analysis. Lancet Infect. Dis. 19, 203\u2013214 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"27074_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/fmb-2017-0128","volume":"13","author":"EP Parker","year":"2018","unstructured":"Parker, E. P. et al. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 13, 97\u2013118 (2018).","journal-title":"Future Microbiol."},{"key":"27074_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/civ828","volume":"62","author":"SS Moon","year":"2016","unstructured":"Moon, S. S. et al. Prevaccination rotavirus serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants. Clin. Infect. Dis. 62, 157\u2013165 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"27074_CR9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","volume":"171","author":"M Voysey","year":"2017","unstructured":"Voysey, M. et al. The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis. JAMA Pediatr. 171, 637\u2013646 (2017).","journal-title":"JAMA Pediatr."},{"key":"27074_CR10","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","volume":"2","author":"C Naylor","year":"2015","unstructured":"Naylor, C. et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in bangladesh. EBioMedicine 2, 1759\u20131766 (2015).","journal-title":"EBioMedicine"},{"key":"27074_CR11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/fmb-2018-0016","volume":"13","author":"JA Church","year":"2018","unstructured":"Church, J. A. et al. Exploring the relationship between environmental enteric dysfunction and oral vaccine responses. Future Microbiol. 13, 1055\u20131070 (2018).","journal-title":"Future Microbiol."},{"key":"27074_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiw518","volume":"215","author":"VC Harris","year":"2017","unstructured":"Harris, V. C. et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J. Infect. Dis. 215, 34\u201341 (2017).","journal-title":"J. Infect. Dis."},{"key":"27074_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vaccine.2017.11.031","volume":"36","author":"EPK Parker","year":"2018","unstructured":"Parker, E. P. K. et al. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine 36, 264\u2013272 (2018).","journal-title":"Vaccine"},{"key":"27074_CR14","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.vaccine.2020.01.097","volume":"38","author":"JA Church","year":"2020","unstructured":"Church, J. A. et al. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants. Vaccine 38, 2870\u20132878 (2020).","journal-title":"Vaccine"},{"key":"27074_CR15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/infdis\/jiz002","volume":"219","author":"A Bennett","year":"2019","unstructured":"Bennett, A. et al. Infrequent transmission of monovalent human rotavirus vaccine virus to household contacts of vaccinated infants in Malawi. J. Infect. Dis. 219, 1730\u20131734 (2019).","journal-title":"J. Infect. Dis."},{"key":"27074_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vaccine.2017.07.116","volume":"36","author":"RP Lazarus","year":"2018","unstructured":"Lazarus, R. P. et al. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: a randomized, factorial design, placebo-controlled study among Indian infants. Vaccine 36, 273\u2013279 (2018).","journal-title":"Vaccine"},{"key":"27074_CR17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/infdis\/jit166","volume":"208","author":"M Patel","year":"2013","unstructured":"Patel, M. et al. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J. Infect. Dis. 208, 284\u2013294 (2013).","journal-title":"J. Infect. Dis."},{"key":"27074_CR18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/infdis\/jix310","volume":"216","author":"JA Lewnard","year":"2017","unstructured":"Lewnard, J. A. et al. Naturally acquired immunity against rotavirus infection and gastroenteritis in children: paired reanalyses of birth cohort studies. J. Infect. Dis. 216, 317\u2013326 (2017).","journal-title":"J. Infect. Dis."},{"key":"27074_CR19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/infdis\/167.3.577","volume":"167","author":"DO Matson","year":"1993","unstructured":"Matson, D. O., O\u2019Ryan, M. L., Herrera, I., Pickering, L. K. & Estes, M. K. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167, 577\u2013583 (1993).","journal-title":"J. Infect. Dis."},{"key":"27074_CR20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/INF.0b013e3181e232ea","volume":"29","author":"SS Moon","year":"2010","unstructured":"Moon, S. S. et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr. Infect. Dis. J. 29, 919\u2013923 (2010).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"27074_CR21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/INF.0b013e318290646d","volume":"32","author":"SS Moon","year":"2013","unstructured":"Moon, S. S. et al. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr. Infect. Dis. J. 32, 863\u2013870 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"27074_CR22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/aje\/kwq050","volume":"171","author":"G Phillips","year":"2010","unstructured":"Phillips, G., Lopman, B., Rodrigues, L. C. & Tam, C. C. Asymptomatic rotavirus infections in England: prevalence, characteristics, and risk factors. Am. J. Epidemiol. 171, 1023\u20131030 (2010).","journal-title":"Am. J. Epidemiol."},{"key":"27074_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/adc.78.3.235","volume":"78","author":"LT Weaver","year":"1998","unstructured":"Weaver, L. T., Arthur, H. M., Bunn, J. E. & Thomas, J. E. Human milk IgA concentrations during the first year of lactation. Arch. Dis. Child 78, 235\u2013239 (1998).","journal-title":"Arch. Dis. Child"},{"key":"27074_CR24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/emph\/eoz030","volume":"2019","author":"M Fujita","year":"2019","unstructured":"Fujita, M., Wander, K., Paredes Ruvalcaba, N. & Brindle, E. Human milk sIgA antibody in relation to maternal nutrition and infant vulnerability in northern Kenya. Evol. Med Public Health 2019, 201\u2013211 (2019).","journal-title":"Evol. Med Public Health"},{"key":"27074_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/INF.0000000000000481","volume":"34","author":"S Becker-Dreps","year":"2015","unstructured":"Becker-Dreps, S. et al. Rotavirus-specific IgG antibodies from mothers\u2019 serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr. Infect. Dis. J. 34, 115\u2013116 (2015).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"27074_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19718-y","volume":"8","author":"F Bucardo","year":"2018","unstructured":"Bucardo, F. et al. The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children. Sci. Rep. 8, 1502 (2018).","journal-title":"Sci. Rep."},{"key":"27074_CR27","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/21645515.2016.1274474","volume":"13","author":"MY Chen","year":"2017","unstructured":"Chen, M. Y. et al. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand. Hum. Vaccin Immunother. 13, 1126\u20131135 (2017).","journal-title":"Hum. Vaccin Immunother."},{"key":"27074_CR28","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1128\/JVI.03518-12","volume":"87","author":"S Ramani","year":"2013","unstructured":"Ramani, S. et al. The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J. Virol. 87, 7255\u20137264 (2013).","journal-title":"J. Virol."},{"key":"27074_CR29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1706804","volume":"378","author":"JE Bines","year":"2018","unstructured":"Bines, J. E. et al. Human neonatal rotavirus vaccine (RV3-BB) to target rotavirus from birth. N. Engl. J. Med. 378, 719\u2013730 (2018).","journal-title":"N. Engl. J. Med"},{"key":"27074_CR30","doi-asserted-by":"publisher","unstructured":"Huda, M. N. et al. Bifidobacterium abundance in early infancy and vaccine response at 2 years of age. Pediatrics 143, https:\/\/doi.org\/10.1542\/peds.2018-1489 (2019).","DOI":"10.1542\/peds.2018-1489"},{"key":"27074_CR31","doi-asserted-by":"crossref","unstructured":"Abrahamsson, T. R. et al. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 129, 434-440, 440.e431-432 (2012).","DOI":"10.1016\/j.jaci.2011.10.025"},{"key":"27074_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fped.2017.00111","volume":"5","author":"N Amenyogbe","year":"2017","unstructured":"Amenyogbe, N., Kollmann, T. R. & Ben-Othman, R. Early-life host-microbiome interphase: the key frontier for immune development. Front Pediatr. 5, 111 (2017).","journal-title":"Front Pediatr."},{"key":"27074_CR33","doi-asserted-by":"publisher","unstructured":"Gehrig, J. L. et al. Effects of microbiota-directed foods in gnotobiotic animals and undernourished children. Science 365, https:\/\/doi.org\/10.1126\/science.aau4732 (2019).","DOI":"10.1126\/science.aau4732"},{"key":"27074_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature13421","volume":"510","author":"S Subramanian","year":"2014","unstructured":"Subramanian, S. et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510, 417\u2013421 (2014).","journal-title":"Nature"},{"key":"27074_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89\u2013100 e105 (2018).","journal-title":"Cell Host Microbe"},{"key":"27074_CR36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature24460","volume":"551","author":"D Vandeputte","year":"2017","unstructured":"Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507\u2013511 (2017).","journal-title":"Nature"},{"key":"27074_CR37","doi-asserted-by":"crossref","first-page":"e016577","DOI":"10.1136\/bmjopen-2017-016577","volume":"7","author":"KN Sindhu","year":"2017","unstructured":"Sindhu, K. N. et al. Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study. BMJ Open 7, e016577 (2017).","journal-title":"BMJ Open"},{"key":"27074_CR38","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1016\/j.vaccine.2014.03.039","volume":"32","author":"A Paul","year":"2014","unstructured":"Paul, A., Gladstone, B. P., Mukhopadhya, I. & Kang, G. Rotavirus infections in a community based cohort in Vellore, India. Vaccine 32, A49\u2013A54 (2014).","journal-title":"Vaccine"},{"key":"27074_CR39","doi-asserted-by":"crossref","first-page":"e1560","DOI":"10.7717\/peerj.1560","volume":"4","author":"R Gautam","year":"2016","unstructured":"Gautam, R. et al. One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix(R) and RotaTeq(R)) in stool samples. PeerJ 4, e1560 (2016).","journal-title":"PeerJ"},{"key":"27074_CR40","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1128\/JVI.76.13.6596-6601.2002","volume":"76","author":"M Iturriza Gomara","year":"2002","unstructured":"Iturriza Gomara, M., Wong, C., Blome, S., Desselberger, U. & Gray, J. Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation. J. Virol. 76, 6596\u20136601 (2002).","journal-title":"J. Virol."},{"key":"27074_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"27074_CR42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"27074_CR43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"27074_CR44","doi-asserted-by":"publisher","unstructured":"Davis, N. M., Proctor, D. M., Holmes, S. P., Relman, D. A. & Callahan, B. J. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome 6, https:\/\/doi.org\/10.1186\/s40168-018-0605-2 (2018).","DOI":"10.1186\/s40168-018-0605-2"},{"key":"27074_CR45","volume":"21","author":"X Zhang","year":"2020","unstructured":"Zhang, X. & Yi, N. NBZIMM: negative binomial and zero-inflated mixed models, with application to microbiome\/metagenomics data analysis. BMC Bioinforma. 21, 488 (2020).","journal-title":"BMC Bioinforma."},{"key":"27074_CR46","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.5528337","author":"EPK Parker","year":"2021","unstructured":"Parker, E. P. K. et al. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants. Github Repos. https:\/\/doi.org\/10.5281\/zenodo.5528337 (2021).","journal-title":"Github Repos."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27074-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T14:44:22Z","timestamp":1669992262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27074"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27074-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.02.20224576","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.I.G. has received research grants from GSK and Merck, and has provided expert advice to GSK. K.C.J. and N.A.C. have received investigator-initiated research grant support from GSK. N.A.C. has received research grant support and honoraria for participation in rotavirus vaccine data safety monitoring committee meetings from GSK. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7288"}}